Short Interest in Hypermarcas (OTCMKTS:HYPMY) Decreases By 43.9%

Hypermarcas (OTCMKTS:HYPMY) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 3,256 shares, a drop of 43.9% from the July 15th total of 5,807 shares. Based on an average daily trading volume, of 19,962 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the company’s stock are short sold.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Zacks Research raised Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. Jefferies Financial Group raised shares of Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy”.

Hypermarcas Stock Performance

HYPMY traded down $0.12 on Monday, hitting $4.08. 699 shares of the company were exchanged, compared to its average volume of 22,021. Hypermarcas has a 12 month low of $3.71 and a 12 month high of $5.50. The company has a market cap of $2.87 billion, a PE ratio of 8.15 and a beta of 0.70. The stock’s fifty day moving average is $4.09 and its 200-day moving average is $4.34.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.13 by $0.01. Hypermarcas had a return on equity of 14.63% and a net margin of 19.77%. As a group, equities research analysts expect that Hypermarcas will post 0.53 EPS for the current fiscal year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.